Vered Livneh
Overview
Explore the profile of Vered Livneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Livneh V, Faust-Socher A, Cohen M, Schechter Y, Israel I, Eichel R, et al.
CNS Neurol Disord Drug Targets
. 2025 Jan;
PMID: 39838672
Background: Botulinum Toxin type A (BonTA) is the preferred treatment for Cervical Dystonia (CD). However, the success rate is often suboptimal. One of the reasons for treatment failure is the...
2.
Thaler A, Anis S, Ponger P, Fay-Karmon T, Livneh V, Faust-Socher A, et al.
Parkinsonism Relat Disord
. 2024 Aug;
127:107115.
PMID: 39208588
Background: Advanced Parkinson's disease (PD) can be treated with Levodopa-Carbidopa Intestinal Gel (LCIG). Objective: To compare descriptive data of LCIG treatment in GBA1-PD and LRRK2-PD. Methods: This multicenter retrospective study...
3.
Yahalom G, Fay-Karmon T, Livneh V, Israeli-Korn S, Ephraty L, Hassin-Baer S
Neurotox Res
. 2021 May;
39(4):1352-1359.
PMID: 34050898
Botulinum toxin (BT) injections into the cervical muscles are an effective and commonly practiced treatment approach for cervical dystonia. In this retrospective longitudinal study, we collected data from the Sheba...
4.
Rosenblum S, Meyer S, Gemerman N, Mentzer L, Richardson A, Israeli-Korn S, et al.
Mov Disord Clin Pract
. 2020 Aug;
7(6):648-655.
PMID: 32775510
Background: Administering an abbreviated global cognitive test, such as the Montreal Cognitive Assessment (MoCA), is necessary for the recommended first-level diagnostic criteria for mild cognitive impairment (MCI) in Parkinson's disease...
5.
Yahalom G, Yekutieli Z, Israeli-Korn S, Elincx-Benizri S, Livneh V, Fay-Karmon T, et al.
Isr Med Assoc J
. 2020 Jan;
22(1):37-42.
PMID: 31927804
Background: There is a need for standardized and objective methods to measure postural instability (PI) and gait dysfunction in Parkinson's disease (PD) patients. Recent technological advances in wearable devices, including...
6.
Yahalom H, Israeli-Korn S, Linder M, Yekutieli Z, Karlinsky K, Rubel Y, et al.
Clin Neuropharmacol
. 2019 Dec;
43(1):1-6.
PMID: 31815747
Objectives: We aimed to characterize parkinsonian features and gait performance of psychiatric patients on neuroleptics (PPN) and to compare them to Parkinson's disease (PD) and healthy controls (HC). Methods: Hospitalized...
7.
Yahalom G, Greenbaum L, Israeli-Korn S, Fay-Karmon T, Livneh V, Ruskey J, et al.
Parkinsonism Relat Disord
. 2018 Dec;
62:179-184.
PMID: 30573413
Introduction: The clinical characteristics of Parkinson's disease (PD) associated with both the LRRK2 p.G2019S mutation and a GBA variant (LRRK2-GBA-PD) have not yet been determined. Methods: In this retrospective observational...
8.
Ruskey J, Greenbaum L, Ronciere L, Alam A, Spiegelman D, Liong C, et al.
Eur J Med Genet
. 2018 May;
62(1):65-69.
PMID: 29842932
Background: Variants in GBA are the most common genetic risk factor for Parkinson's disease (PD), and are especially prevalent in the Ashkenazi Jewish (AJ) population. However, most studies on GBA...
9.
Steiner I, Livneh V, Hoffmann C, Nass D, Mor O, Chapman J
Ann Neurol
. 2014 May;
75(6):967-70.
PMID: 24817010
Chronic measles virus infection of the brain causes subacute sclerosing panencephalitis (SSPE), a progressive, relentless fatal disorder. We report a 52-year-old male who developed focal, chronic persistent measles virus infection...